References | Country | Study design | QoL instrument | Sample size with AT | Mean Age | Gender distribution | Symptoms’ duration | Quality assessment result |
---|---|---|---|---|---|---|---|---|
Plinsinga et al. [19] | Australia | Case–control | EQ-5D, hospital anxiety and depression scale, TSK | 75 | AT: 45.7, Control: 41 | AT: M: 17, F: 13, Control: M: 6, F:5 | Moderate 9 | |
Ceravolo et al. [20] | Australia | Exploratory study | AQoL-8D | 92 | M: 49, F:43 | Moderate 8 | ||
Turner et al. [21] | Australia | Qualitative, interpretive description design | Semi-structured telephone interviews VISA-A | 15 | 45.2 | M:8, F:7 | Eight months | Moderate 7 |
Nørregaard et al. [22] | Denmark | Modification KOOS | 53 | 42 | 28.5 months | High 11 | ||
Petersen et al. [23] | Germany | Prospective Randomised Study | SF-36 | 100 | 42.5 | M:60, F:40 | 7.4 months | High 11 |
Knobloch et al. [24] | Germany | Cohort Study | FAOS | 86 | M:38, F:25 | 7 months | High 10 | |
Dedes et al. [25] | Greece | Cross-sectional | UoP-PFQ | 130 | M:60, F:70 | High 11 | ||
Mc Auliffe et al. [26] | Ireland | Qualitative interpretive description design | Semi-structured telephone interviews, VISA-A | 8 | 40 | M:6, F: 2 | 20.5 months | Moderate 9 |
Opdam et al. [27] | Nether-lands | Retrospective | FAOS | 59 | 50 | M:18, F:27 | 45 months | High 11 |
Sleeswijk et al. [2] | Nether-lands | Cross-sectional | EQ-5D | 80 | 50 | M:39, F:41 | 15.7 months | High 11 |
Chester et al. [28] | Norwich | Pilot Study | VISA-A, EQ-5D | 16 | 53.5 | M: 11, F: 5 | 19 months | High 11 |
Roos et al. [29] | Sweden | Randomised study | FAOS | 44 | 46 | M:21, F:23 | 5.5 months | High 10 |
Alfredson et al. [30] | Sweden | Pilot study | SF-36 | 24 | M:45, F:50 | M:13, F:11 | 18 months | Moderate 8 |
Deans et al. [31] | UK | Prospective case series | FAOS | 26 | 45.77 | M:10, F:16 | High 10 | |
Maffulli et al. [32] | UK | Cross-sectional | VISA-A, EQ-5D | 82 | 53.18 | M:52, F:30 | High 11 | |
Kearney et al. [33] | UK | Multicenter randomised study | VISA-A, EQ-5D | 240 | 52 | M:102; F:138 | High 10 | |
Mallows et al. [34] | UK | Qualitative interpretive description design | Semi-structured interviews | 10 | 49.2 | M:6, F:4 | 12.9 months | High 11 |
Lewis et al. [35] | UK | Prospective comparative observational study | VISA-A, EQ-5D | 320 | 52.1 | M:125, F:195 | High 11 | |
Martin et al. [36] | US | Cross-sectional | SF-36 | 44 | 58.2 | M: 18, F:26 | 24 months | Moderate 8 |
Chimenti et al. [37] | USA | Retrospective | SF-36 | 34 | 52.2 | 18 months | High 11 | |
Corrigan et al. [38] | USA | Cross-sectional | VISA-A TSK | 53 | 54.5 | M:35, F:18 | 7 months | High 10 |
Phen et al. [39] | USA | Retrospective | SF-36 | 37 | < 60: 49.1, > 60: 66.8 | < 60: M:5, F:16, > 60: M:2, F:15 | High 11 | |
Chimeti et al. [40] | USA, Australia, Germany, India, New Zeland, UK | Cross-sectional | TSK-11 | 442 | 36.3 | M:191, F:251 | High 10 |